The US Food and Drug Administration (USFDA) has said Sun Pharma and Zydus Pharmaceuticals are recalling products in the US ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

Discover why pharmaceutical-grade supplements command premium prices and whether their higher standards of purity, potency ...

The Wasatch U.S. Select Fund—Investor Class gained 0.24% but underperformed the benchmark Russell 3000® Growth Index, which ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

One neat trick involves requesting that prescriptions be processed under a “universal Rx code,” which a pharmacy customer found reduced her medication cost from $252 to $51, suggesting that this ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

The U.K. government proposes raising mandatory drug rebates paid by drug companies to bolster the National Health Service.

As Filipinos increasingly prioritize health and wellness, Sole Pharma, a leading European pharmaceutical manufacturer, ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.